Shares of Alexza Pharmaceuticals (ALXA) fall off another 16%, and have now given back almost all...

|About: Alexza Pharmaceuticals, Inc. (ALXA)|By:, SA News Editor

Shares of Alexza Pharmaceuticals (ALXA) fall off another 16%, and have now given back almost all of their gains from Tuesday's rocket ride following FDA approval for Adasuve. An influence on ALXA's share price could be a FDA panel that TheStreet.com's Adam Feurstein calls "confusing."